retatrutide mechanism gip glp-1 glucagon triple agonist Frontiers retatrutide mechanism glp-1 gip glucagon

Effects on Blood Sugar Control and Insulin Secretion The primary indication for GLP-1 receptor agonists is the management of type 2 diabetes mellitus , where they exert potent effects on glycaemic control through multiple complementary mechanisms

the extensive mechanisms that regulate polyamine synthesis and trafficking often complicate efforts to modify their levels, especially locally (Miller-Fleming et al., 2015)

Its molecular structure resists deactivation, allowing it to operate longer within the body

Advanced formulations allow for sustained release of therapeutic agents, reducing dosing frequency and improving patient compliance